Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycin

Author(s):

Adrianna M. Turner, Lucy Li, Ian R. Monk, Jean Y.H. Lee, Danielle J. Ingle, Stephanie Portelli, Norelle L. Sherry, Nicole Isles, Torsten Seemann, Liam K. Sharkey, Calum J. Walsh, Gavin E. Reid, Shuai Nie, Bart A. Eijkelkamp, Natasha E. Holmes, Brennan Collis, Sara Vogrin, Andreas Hiergeist, Daniela Weber, Andre Gessner, Ernst Holler, David B. Ascher, Sebastian Duchene, Nichollas E. Scott, Timothy P. Stinear, Jason C. Kwong, Claire L. Gorrie, Benjamin P. Howden, Glen P. Carter

Details:

Nature, Volume 635, Issue 8040, 2024-11-28

Article Link: Click here

Affiliations:

• University of Melbourne
• The University of Queensland
• Institut Pasteur, Paris
• Klinikum der Universität Regensburg und Medizinische Fakultät
• Austin Health
• Baker Heart and Diabetes Institute
• Monash Health
• Bio21 Molecular Science and Biotechnology Institute
• The Peter Doherty Institute for Infection and Immunity
• College of Science and Engineering
• School of Chemistry